Compare SPCE & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SPCE | XBIT |
|---|---|---|
| Founded | 2017 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Transportation Services | Pharmaceuticals and Biotechnology |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 226.9M | 69.5M |
| IPO Year | N/A | 2015 |
| Metric | SPCE | XBIT |
|---|---|---|
| Price | $3.25 | $2.44 |
| Analyst Decision | Hold | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $9.22 | N/A |
| AVG Volume (30 Days) | ★ 3.8M | 73.6K |
| Earning Date | 11-13-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,661,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2,656.89 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.18 | $2.09 |
| 52 Week High | $6.82 | $7.24 |
| Indicator | SPCE | XBIT |
|---|---|---|
| Relative Strength Index (RSI) | 39.43 | 48.15 |
| Support Level | $3.71 | $2.15 |
| Resistance Level | $4.57 | $2.65 |
| Average True Range (ATR) | 0.26 | 0.15 |
| MACD | -0.05 | 0.02 |
| Stochastic Oscillator | 4.01 | 33.33 |
Virgin Galactic Holdings Inc is a United States-based vertically integrated aerospace company pioneering human spaceflight for private individuals & researchers, and it also manufactures air and space vehicles. Using technologies, the company is developing a spaceflight system designed to offer its customers a multi-day, and transformative experience. This culminates in a spaceflight that includes views of Earth from space and several minutes of weightlessness that will launch from Spaceport America, New Mexico.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.